We are live on ! Find out more
TRV GP VI

TRV GP VI Portfolio holdings

AUM $232M Turnover 25%
1-Year Est. Return 247.08%
This Fund
S&P 500
This Quarter Est. Return
+32.79%
1 Year Est. Return
+247.08%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$232M
AUM Growth
+$96.7M
Cap. Flow
+$36.3M
Cap. Flow %
15.61%
Top 10 Hldgs %
100%
Holding
4
New
1
Increased
–
Reduced
–
Closed
–
Avg Time Held
1.1 years
Top 10 Avg Time Held
1.1 years
Top 20 Avg Time Held
1.1 years

Top Buys

Rank Stock Value
1
SPTX icon
Seaport Therapeutics
SPTX
+$36.3M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
SEPN icon
1
Septerna Inc
SEPN
$2.11B
$141M 60.72%
4,211,659
– –
2024 Q4
6 quarters
SPTX icon
2
Seaport Therapeutics
SPTX
$1.13B
$44.8M 19.27%
+2,061,222
New +$36.3M
2026 Q2
0 quarters
RAPP icon
3
Rapport Therapeutics
RAPP
$1.16B
$40.4M 17.39%
969,218
– –
2024 Q4
6 quarters
TNGX icon
4
Tango Therapeutics
TNGX
$3.8B
$6.07M 2.61%
194,174
– –
2024 Q4
6 quarters

Similar funds

EMB
Elefante Mark B $232M AUM 39.33% 1-Year Est. Return
2Xideas
2Xideas Kusnacht, Switzerland $232M AUM 4.22% 1-Year Est. Return
Cooper/Haims Advisors
Cooper/Haims Advisors Victor, New York $232M AUM 17.89% 1-Year Est. Return
PC
Panoramic Capital Larkspur, California $232M AUM 255.07% 1-Year Est. Return
ShawSpring Partners
ShawSpring Partners Boston, Massachusetts $232M AUM 27.09% 1-Year Est. Return
Lavelle Capital
Lavelle Capital San Francisco, California $232M AUM
ARP Global Capital
ARP Global Capital Dubai $232M AUM
J.H. Whitney Equity Partners VII
J.H. Whitney Equity Partners VII New Canaan, Connecticut $232M AUM 63.86% 1-Year Est. Return

TRV GP VI's Q2 2026 Portfolio in Review

As of Q2 2026, TRV GP VI held 4 positions worth $232M, up 71% from $136M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

TRV GP VI deployed $36.3M of net new capital in Q2 2026, opening 1 new position. Its largest new stake was Seaport Therapeutics: 2,061,222 shares worth $44.8M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • TRV GP VI's largest Q2 2026 buy was Seaport Therapeutics: 2,061,222 shares worth $44.8M.
  • TRV GP VI's ten largest holdings make up 100% of its $232M portfolio in Q2 2026.
  • TRV GP VI opened 1 new position and closed 0 in Q2 2026.
  • TRV GP VI's portfolio value rose 71% quarter-over-quarter to $232M.

Based on TRV GP VI's 13F filing for Q2 2026, filed 10 Aug 2026.